Recent Company News

• 10:54 PM ET Aug 19, 2026
  

  StreetAccount Summary - Trading higher/lower: Japan mid-day

• 07:37 PM ET Oct 14, 2026
  

  Sumitomo Pharma upgraded to overweight from equal-weight at Morgan Stanley (¥1590.5000, 0)

• 02:49 AM ET Sep 30, 2026
  

  Sumitomo Pharma reports topline results from final analysis of phase I Europe study of universal influenza vaccine DSP-0546 (¥1626.5000, 0)

• 12:32 AM ET Aug 31, 2026
  

  Sumitomo Pharma trading higher; selected as one of five constituents of ESG investment index used by Japan GPIF (¥1544.5000, +59.5)

• 07:40 PM ET Aug 12, 2026
  

  Sumitomo Pharma America doses first patient in phase 1/2a study of DSP3077 for retinitis pigmentosa (¥1350.0000, 0)